Amanote Research
Register
Sign In
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
Journal of Oncology
- United States
doi 10.1155/2019/8607859
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
January 1, 2019
Authors
Yan Wu
Dan Jin
Xiaohong Wang
Jing Du
Weihua Di
Jiajia An
Cuijie Shao
Jiwei Guo
Publisher
Hindawi Limited
Related search
Phenylethyl Isothiocyanate Reverses Cisplatin Resistance in Biliary Tract Cancer Cells via Glutathionylation-Dependent Degradation of McL-1
Oncotarget
Oncology
Upregulation of miR-23a∼27a∼24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells
PLoS ONE
Multidisciplinary
YAP Induces Cisplatin Resistance Through Activation of Autophagy in Human Ovarian Carcinoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
Cisplatin Resistance in Gastric Cancer Cells Is Associated With HER2 Upregulation-Induced Epithelial-Mesenchymal Transition
Scientific Reports
Multidisciplinary
Continuous Targeted Kinase Inhibitors Treatment Induces Upregulation of PD-L1 in Resistant NSCLC
Scientific Reports
Multidisciplinary
Exosomal Transfer of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance in NSCLC Through Activating Autophagy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Administration of Follicle-Stimulating Hormone Induces Autophagy via Upregulation of HIF-1α in Mouse Granulosa Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
CLEC4M Is Associated With Poor Prognosis and Promotes Cisplatin Resistance in NSCLC Patients
Journal of Cancer
Oncology
